国际生殖健康/计划生育杂志
國際生殖健康/計劃生育雜誌
국제생식건강/계화생육잡지
JOURNLA OF INTERNATIONAL REPRODUCTIVE HEALTH/FAMILY PLANNING
2015年
5期
368-371
,共4页
董娟%蔡令波%曾桥%马龙%夏梦%刘嘉茵%千日成
董娟%蔡令波%曾橋%馬龍%夏夢%劉嘉茵%韆日成
동연%채령파%증교%마룡%하몽%류가인%천일성
受精,体外%胚胎移植%生殖技术,辅助%胚胎评分
受精,體外%胚胎移植%生殖技術,輔助%胚胎評分
수정,체외%배태이식%생식기술,보조%배태평분
Fertilization in vitro%Embryo transfer%Reproductive techniques,assisted%Embryo score
目的:比较人类胚胎体外培养第3天4种胚胎移植策略的临床结局。方法:回顾性分析了本中心2010年1月—2012年12月收治的≤35岁患者的第3天胚胎移植周期,均为第一次促排卵周期,采用控制性促排卵长方案和短方案,排除供精周期和遗传性疾病患者,获卵数≥2个。根据移植胚胎数及评分(评为Ⅰ、Ⅱ、Ⅲ、Ⅳ级,Ⅰ、Ⅱ级为高评分胚胎,Ⅲ、Ⅳ级为低评分胚胎)分为4组:A组移植1枚高评分胚胎,B组移植2枚高评分胚胎,C组移植1枚高评分胚胎和1枚低评分胚胎,D组移植2枚低评分胚胎。比较4组的临床妊娠率、胚胎着床率、双胎率、流产率和活产率。结果:4组的流产率分别为8.67%、10.34%、13.54%、20.00%,差异无统计学意义(χ2=4.146,P=0.246);B组的每周期临床妊娠率和活产率分别为55.94%、49.38%,均高于A组(32.05%、28.63%)和C组(42.86%、37.72%),差异有统计学意义(P<0.0001),C组的每周期临床妊娠率和活产率高于A组,差异有统计学意义(P<0.01);然而,B组的双胎率(36.31%)高于A组(0.67%)和C组(27.60%),差异有统计学意义(P<0.01)。结论:选择1枚高评分胚胎与1枚低评分胚胎协同移植,可获得可接受的每周期临床妊娠率和活产率,亦未提高双胎率。
目的:比較人類胚胎體外培養第3天4種胚胎移植策略的臨床結跼。方法:迴顧性分析瞭本中心2010年1月—2012年12月收治的≤35歲患者的第3天胚胎移植週期,均為第一次促排卵週期,採用控製性促排卵長方案和短方案,排除供精週期和遺傳性疾病患者,穫卵數≥2箇。根據移植胚胎數及評分(評為Ⅰ、Ⅱ、Ⅲ、Ⅳ級,Ⅰ、Ⅱ級為高評分胚胎,Ⅲ、Ⅳ級為低評分胚胎)分為4組:A組移植1枚高評分胚胎,B組移植2枚高評分胚胎,C組移植1枚高評分胚胎和1枚低評分胚胎,D組移植2枚低評分胚胎。比較4組的臨床妊娠率、胚胎著床率、雙胎率、流產率和活產率。結果:4組的流產率分彆為8.67%、10.34%、13.54%、20.00%,差異無統計學意義(χ2=4.146,P=0.246);B組的每週期臨床妊娠率和活產率分彆為55.94%、49.38%,均高于A組(32.05%、28.63%)和C組(42.86%、37.72%),差異有統計學意義(P<0.0001),C組的每週期臨床妊娠率和活產率高于A組,差異有統計學意義(P<0.01);然而,B組的雙胎率(36.31%)高于A組(0.67%)和C組(27.60%),差異有統計學意義(P<0.01)。結論:選擇1枚高評分胚胎與1枚低評分胚胎協同移植,可穫得可接受的每週期臨床妊娠率和活產率,亦未提高雙胎率。
목적:비교인류배태체외배양제3천4충배태이식책략적림상결국。방법:회고성분석료본중심2010년1월—2012년12월수치적≤35세환자적제3천배태이식주기,균위제일차촉배란주기,채용공제성촉배란장방안화단방안,배제공정주기화유전성질병환자,획란수≥2개。근거이식배태수급평분(평위Ⅰ、Ⅱ、Ⅲ、Ⅳ급,Ⅰ、Ⅱ급위고평분배태,Ⅲ、Ⅳ급위저평분배태)분위4조:A조이식1매고평분배태,B조이식2매고평분배태,C조이식1매고평분배태화1매저평분배태,D조이식2매저평분배태。비교4조적림상임신솔、배태착상솔、쌍태솔、유산솔화활산솔。결과:4조적유산솔분별위8.67%、10.34%、13.54%、20.00%,차이무통계학의의(χ2=4.146,P=0.246);B조적매주기림상임신솔화활산솔분별위55.94%、49.38%,균고우A조(32.05%、28.63%)화C조(42.86%、37.72%),차이유통계학의의(P<0.0001),C조적매주기림상임신솔화활산솔고우A조,차이유통계학의의(P<0.01);연이,B조적쌍태솔(36.31%)고우A조(0.67%)화C조(27.60%),차이유통계학의의(P<0.01)。결론:선택1매고평분배태여1매저평분배태협동이식,가획득가접수적매주기림상임신솔화활산솔,역미제고쌍태솔。
Objective: To compare the clinical outcomes of different strategies of embryo-transfer (ET) on the day 3 of in vitro cultured embryos in IVF treatment cycles. Methods:This is a retrospective study on those ET cycles on the day 3 of in vitro cultured embryos in those patients aged lower than or equal to 35 years in our IVF center from January 2010 to December 2012. All cycles were the first stimulated ovulation induced by long and short programs. The sperm-donor cycles and the genetic diseases cycles were excluded. Ocytes in every cycle were more than or equal to two. The strategies of ET were divided into four groups, based on the embryo number of ET and the embryo score (embryos were scored asⅠ, Ⅱ, Ⅲ, Ⅳ; while Ⅰ and Ⅱ were considered as high-score embryos andⅢandⅣas low-score embryos). Group A, transfer one high-score embryo;Group B, transfer two high-score embryos; Group C, transfer one high-score embryo and one low-score embryo; and Group D, transfer two low-score embryos. The rates of clinical pregnancy, implantation, twin pregnancy, miscarriage and live birth among 4 groups were compared. Results:There was not significant difference in the miscarriage rates among four groups (8.67%, 10.34%, 13.54%, 20.00%; χ2=4.146,P=0.246). The rates of clinical pregnancy and live birth per ET cycle in the group B (55.94%, 49.38%) were significantly higher than those in the group A (32.05%、28.63%) and the group C (42.86%, 37.72%), respectively (P<0.000 1). The rates of clinical pregnancy and live birth per ET cycle in the group C were significantly higher than those in the group A (P<0.01). However, the rate of twin pregnancy in the group B (36.31%) was significantly higher than those in the group A (0.67%) and the group C (23.96%) (P<0.01). Conclusions:The strategy of ET of one high-score embryo combined with one low-score embryo can get acceptable rates of clinical pregnancy and live birth per ET cycle, while it does not increase the rate of twin pregnancy.